RxDoctor Payments Data

Ronald Iannacone, DO

Facial Plastic Surgery · Manasquan, NJNPI 1558346825

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,066 of the $4,288 with a category attached, or 71.5%. It is spread thinly across 14 manufacturers, the largest accounting for just 16.7%. 2025 is the largest year on record at $1,280, more than ten times the $58 reported in 2019.

$4,288in general payments, 2019–2025

Across 165 payments — averaging $25.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$717
  • Regeneron Healthcare Solutions, Inc.$685
  • Aerin Medical Inc.$654
  • Medical Device Business Services, Inc.$561
  • GSK$510
  • Sanofi$450
  • plus $710 from 8 others

What the payments were for

  • Travel & lodging$1,12426%
  • Food & beverage$3,06671%
  • Education$982%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,288 in reported general payments places this provider in the 85th percentile of 22 facial plastic surgery providers in New Jersey.

See all facial plastic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$524,900
Medicare patients
1,212
Services billed
3,260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab23$85,996
Ipratropium Bromide364$11,087
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth27$2,865
Doxycycline Hyclate303$2,442
Mometasone Furoate138$1,377
Tobramycin-DexamethasoneTobramycin/Dexamethasone32$1,149
Methylprednisolone193$967
Fluticasone Propionate69$932
Fluconazole33$470
Meclizine Hcl48$375
Montelukast Sodium34$348
Mupirocin39$332
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen50$320
Prednisone235$290
Nystatin34$272

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Manasquan

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →